Confluence Investment Management LLC Has $488,000 Stake in Roche Holding AG (OTCMKTS:RHHBY)

Confluence Investment Management LLC increased its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY) by 26.3% during the fourth quarter, Holdings Channel reports. The fund owned 13,981 shares of the company’s stock after acquiring an additional 2,910 shares during the quarter. Confluence Investment Management LLC’s holdings in Roche were worth $488,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in RHHBY. Altrius Capital Management Inc lifted its position in Roche by 6.0% during the second quarter. Altrius Capital Management Inc now owns 224,804 shares of the company’s stock worth $7,794,000 after acquiring an additional 12,646 shares during the last quarter. Kornitzer Capital Management Inc. KS lifted its holdings in Roche by 1.3% during the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 136,923 shares of the company’s stock worth $5,490,000 after purchasing an additional 1,798 shares during the last quarter. Rhumbline Advisers boosted its stake in Roche by 0.9% in the 2nd quarter. Rhumbline Advisers now owns 103,985 shares of the company’s stock valued at $3,605,000 after purchasing an additional 904 shares during the period. Bard Financial Services Inc. grew its holdings in Roche by 156.8% in the 3rd quarter. Bard Financial Services Inc. now owns 80,500 shares of the company’s stock valued at $3,216,000 after buying an additional 49,150 shares in the last quarter. Finally, Diversified Trust Co increased its position in Roche by 6.4% during the 3rd quarter. Diversified Trust Co now owns 59,742 shares of the company’s stock worth $2,396,000 after buying an additional 3,613 shares during the period.

Roche Trading Up 0.2 %

OTCMKTS:RHHBY opened at $34.94 on Friday. Roche Holding AG has a fifty-two week low of $29.20 and a fifty-two week high of $42.43. The stock has a fifty day moving average price of $36.50 and a 200-day moving average price of $37.94.

Analyst Ratings Changes

A number of brokerages have recently issued reports on RHHBY. Deutsche Bank Aktiengesellschaft cut shares of Roche from a “hold” rating to a “sell” rating in a research report on Friday, September 13th. Bank of America raised shares of Roche from a “neutral” rating to a “buy” rating in a report on Friday, September 13th. Three investment analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.